Sort
40,608 grants matching “prostate cancer”
Novel Targets for Vaccine Therapy
$960,254Claudia Palena · Division Of Basic Sciences - Nci · ZIC · FY2010 · CA
INTEGRATED ULTRASONIC SYSTEMS FOR NONINVASIVE THERAPY
$960,100Riverside Research Institute · R01 · FY2004 · CA
Vaccine and immunotherapy strategies for cancer and viruses causing cancer
$960,045Jay A Berzofsky · Division Of Clinical Sciences - Nci · ZIA · FY2022 · CA
ABERRANT WOUND HEALING PROVIDES INSIGHTS IN THE BIOLOGY OF PROSTATE CANCER DISPARITIES.
$960,000Tuskegee University · · FY2021 · Defense Health Agency
Mechanisms governing metastatic dormancy and reactivation
$959,998Filippo G Giancotti · University Of Tx Md Anderson Can Ctr · R35 · FY2017 · CA
Mechanisms governing metastatic dormancy and reactivation
$959,998Filippo G Giancotti · University Of Tx Md Anderson Can Ctr · R35 · FY2020 · CA
Mechanisms governing metastatic dormancy and reactivation
$959,998Filippo G Giancotti · University Of Tx Md Anderson Can Ctr · R35 · FY2018 · CA
Mechanisms governing metastatic dormancy and reactivation
$959,998Filippo G Giancotti · University Of Tx Md Anderson Can Ctr · R35 · FY2016 · CA
Mechanisms governing metastatic dormancy and reactivation
$959,994Filippo G Giancotti · Columbia University Health Sciences · R35 · FY2021 · CA
IDENTIFICATION OF NOVEL PROSTATE CANCER STEM CELL GENES AS THERAPEUTIC TARGETS
$959,400University Of Illinois · · FY2019 · Department of the Army
University of Arizona Cancer Prevention Clinical Trials Network (UA CP-CTNet)
$959,375H-H. Sherry Chow · University Of Arizona · UG1 · FY2019 · CA
Targeting Tumor Suppressor Phosphatases For Cancer Therapy
$959,368Pier Paolo Pandolfi · Beth Israel Deaconess Medical Center · U01 · FY2011 · CA
Breast & prostate cancer & hormone-related gene variants
$959,127Elio Riboli · Imperial College Of Science, Technology And Medicine · U01 · FY2006 · CA
Shanghai Men's Health Study
$958,253Xiao-Ou Shu · Vanderbilt University Medical Center · UM1 · FY2017 · CA
Preclinical Alzheimers Disease Drug Development of Novel MAPK Inhibitors
$958,225D. Martin Watterson · Northwestern University At Chicago · U01 · FY2012 · AG
Robust Classification Methods for Categorical Regression
$957,937Steven S Henley · Martingale Research Corporation · R44 · FY2009 · CA
Using Community Health Navigators to Advance Cancer Screening Adherence through Videoconferencing for all Americans who use ASL: A Randomized Controlled Trial Study
$957,649Poorna Kushalnagar · Gallaudet University · U01 · FY2025 · DC
Genetic Epidemiology of Cancer
$957,336Joan E. Bailey-Wilson · Human Genome Research · Z01 · FY2007 · HG
Cell and Cancer Biology Branch Confocal Microscopy Core
$957,040Yvona Ward · Division Of Basic Sciences - Nci · ZIC · FY2011 · CA
Biostatistics Resource
$956,883Donald A Berry · University Of Tx Md Anderson Can Ctr · P30 · FY2010 · CA
Clinical Pharmacogenetics
$956,582William Douglas Figg · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Establishing a Center of Excellence on Health Disparities in Rural Populations
$956,472Jacob C Warren · Georgia Southern University · P20 · FY2013 · MD
A kit based PET agent: edotreotide Ga 68 for clinical imaging of somatostatin rec
$956,175James F Kronauge · Invicro, Llc · R44 · FY2014 · CA
Elucidating and Targeting tumor dependencies and drug resistance determinants at the single cell level
$956,166Andrea Califano · Columbia University Health Sciences · U01 · FY2023 · CA
Avanzando Caminos (Leading Pathways): The Hispanic/Latino Cancer Survivorship Cohort Study.â
$955,889Frank J Penedo · University Of Miami Coral Gables · UG3 · FY2022 · CA